Placebo - Control
13
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (13)
Daridorexant for Alcohol Use Disorder
Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males
Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males
Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males
What is the Role of Type III/IV Muscle Afferents in Airway Resistance and Thermoregulatory Responses to Exercise?
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.
The Effects of Exogenous Ketones on Cognitive Function
Targeted Lidocaine Infusion for Pain Reduction in Office Hysteroscopy
Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy
The Influences of Blood Flow Restriction on Leg Press
Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match
Accuracy of Current Techniques in Quantifying Ketone Levels
Effects of Muscle Flossing on Quadriceps Muscle Potentiation